Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading

被引:43
作者
Feher, Anthony [1 ]
Koivunemi, Andrew [1 ]
Koivunemi, Mark [1 ]
Fuchs, Robyn K. [1 ,4 ]
Burr, David B. [1 ,3 ,5 ]
Phipps, Roger J. [2 ]
Reinwald, Susan [1 ]
Allen, Matthew R. [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA
[2] Proctor & Gamble Pharmaceut Inc, Mason, OH USA
[3] Indiana Univ, Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA
[4] Indiana Univ Purdue Univ, Dept Phys Therapy, Indianapolis, IN 46202 USA
[5] Indiana Univ Purdue Univ, Dept Biomed Engn Program, Indianapolis, IN 46202 USA
关键词
Alendronate; Risedronate; Zoledronate; Ulna loading; Ovariectomy; CORTICAL BONE; MICRODAMAGE ACCUMULATION; OSTEOBLAST ACTIVITY; BIOMECHANICAL PROPERTIES; PARATHYROID-HORMONE; FEMORAL-NECK; ALENDRONATE; TURNOVER; RISEDRONATE; WOMEN;
D O I
10.1016/j.bone.2009.10.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The suppressive effects of bisphosphonates (BPs) on bone remodeling are clear yet there is conflicting data concerning the effects of BPs on modeling (specifically formation modeling on the periosteal surface). The normal periosteal expansion that occurs during aging has significant benefits to maintaining/improving the bones' mechanical Properties and thus it is important to understand whether BPs; affect this bone surface. Therefore, the purpose of this study was to determine the effects of BPs on periosteal bone formation modeling induced by ovariectomy (OVX) and mechanical loading. Six-month-old Sprague-Dawley OVX rats (n=60; 12/group) were administered vehicle, risedronate, alendronate, or zoledronate at doses used clinically for treatment of post-menopausal osteoporosis. Three weeks after initiating BP treatment, all animals underwent in vivo ulnar loading of the right limb every other day for 1 week (3 total sessions). Periosteal surface mineral apposition rate, mineralizing surface, and bone formation rate were determined at the mid-diaphysis of both loaded (right) and non-loaded (left) ulnae. There was no significant effect of any of the BPs on periosteal bone formation parameters compared to VEH-treated animals in the non-loaded limb, suggesting that BP treatment does not compromise the normal periosteal expansion associated with estrogen loss. Mechanical loading significantly increased BFR in the loaded limb compared to the non-loaded limb in all BP-treated groups, with no difference in the magnitude of this effect among the various BPs. Collectively, these data show that BP treatment, at doses comparable to those used for treatment of postmenopausal osteoporosis, (1) does not alter the periosteal formation activity that occurs in the absence of estrogen and (2) allows normal stimulation of periosteal bone formation in response to the anabolic stimulation of mechanical loading. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:203 / 207
页数:5
相关论文
共 49 条
  • [1] Bone loss and bone size after menopause
    Ahlborg, HG
    Johnell, O
    Turner, CH
    Rannevik, G
    Karlsson, MK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) : 327 - 334
  • [2] Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs
    Allen, M. R.
    Burr, D. B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (01) : 95 - 99
  • [3] Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib
    Allen, M. R.
    Follet, H.
    Khurana, M.
    Sato, M.
    Burr, D. B.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2006, 79 (04) : 255 - 261
  • [4] Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate
    Allen, Matthew R.
    Iwata, Ken
    Phipps, Roger
    Burr, David B.
    [J]. BONE, 2006, 39 (04) : 872 - 879
  • [5] Periosteum: biology, regulation, and response to osteoporosis therapies
    Allen, MR
    Hock, JM
    Burr, DB
    [J]. BONE, 2004, 35 (05) : 1003 - 1012
  • [6] BALENA R, 1992, J BONE MINER RES, V7, P1475
  • [7] BARE S, 2005, J BONE MINER RES, V20, pSA414
  • [8] RESPONSE OF CORTICAL BONE TO ANTIRESORPTIVE AGENTS AND PARATHYROID-HORMONE IN AGED OVARIECTOMIZED RATS
    BAUMANN, BD
    WRONSKI, TJ
    [J]. BONE, 1995, 16 (02) : 247 - 253
  • [9] SEX-DIFFERENCES IN GEOMETRY OF THE FEMORAL-NECK WITH AGING - A STRUCTURAL-ANALYSIS OF BONE-MINERAL DATA
    BECK, TJ
    RUFF, CB
    SCOTT, WW
    PLATO, CC
    TOBIN, JD
    QUAN, CA
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1992, 50 (01) : 24 - 29
  • [10] BIKLE DD, 1994, J BONE MINER RES, V9, P1777